Shopping Cart
- Remove All
- Your shopping cart is currently empty
RTC13 is a read-through reagent that restores anti-myasthenia gravis protein expression in the mdx mouse model of Duchenne muscular dystrophy (DMD).
Description | RTC13 is a read-through reagent that restores anti-myasthenia gravis protein expression in the mdx mouse model of Duchenne muscular dystrophy (DMD). |
In vivo | Wild-type (C57BL/10) mice received intraperitoneal injections of RTC13 at different doses of 10, 30, 60, and 300 mg/kg.During autopsy, no significant changes in the weights of the liver and kidneys were observed. In addition, histological examination by hemoglobin and eosin (H&E) staining showed no histopathological changes in these organs. [1] |
Molecular Weight | 315.3 |
Formula | C14H9N3O4S |
Cas No. | 1359825-94-7 |
Smiles | O=[N+](C1=C(C=CC=C1)C2=CC=C(/C=C3C(N=C(S/3)N)=O)O2)[O-] |
Relative Density. | 1.31g/cm3 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (253.73 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.